BIO Digital 2020

SiVEC Biotechnologies will be participating in the BIO International Digital event June 8-12, 2020. Please contact us through the BIO One-on-One Partnering System or reach out by email to schedule a meeting: LLinke@SiVECBiotech.com.

Destination Startup Pitch

SiVEC Biotechnologies has been selected by a panel of over 30 investors, entrepreneurs, and business leaders as one of the most exciting new ventures in the Rocky Mountain region, and is invited to present to angel, venture, and strategic investors at the Destination Startup showcase on February 27, 2020 in Westminster, CO. 

JP Morgan Healthcare 2020

SiVEC Biotechnologies will be in San Francisco again January 13-16, 2020 for CSSi LifeSciences Partnering Forum hosted at the Hilton San Francisco Union Square. We have meeting space available and look forward to a productive partnering event.   

SiVEC Presenting at Rocky Mountain Life Science Investor & Partnering Conference

SiVEC Biotechnologies was selected to pitch at the 2019 Rocky Mountain Life Science Investor & Partnering Conference in Vail, CO on September 4, 2019. We will be featured in the Emerging Technologies track and hope to see you there!

SiVEC Attending 2019 BIO International Convention in Philadelphia

SiVEC Biotechnologies CEO Dr. Lyndsey Linke will be attending the BIO International Convention June 2 through 7, 2019 in Philadelphia, PA. Please reach out if you would like to connect: LLinke@SiVECBiotech.com.

Connect with SiVEC at JP Morgan Healthcare January 2019

SiVEC Biotechnologies will be in San Francisco for the JP Morgan Healthcare Conference on January 7 and 8, 2019. Please let us if you are traveling to or are already in the Bay Area and wish to meet: LLinke@SiVECBiotech.com.

SiVEC Presenting at AAAP

SiVEC Biotechnologies CEO and Co-founder, Dr. Lyndsey Linke, is presenting the results from a recently completed study at the annual meeting of the American Association of Avian Pathologists (AAAP). The focus of this talk will be on the evaluation of protective efficacy of SiVEC-AIV antiviral delivered by spray using industry-standard equipment to commercial layer chickens later challenged with low-pathogenic avian influenza. If you will be in attendance, this presentation will be at 9:00 AM on Tuesday, July 17; please look for the Avian Influenza section, scheduled in room Four Seasons 4 at the Colorado Convention Center. 

Infectious Disease Research Talks

SiVEC Biotechnologies will be presenting on "A Rapid-Response Antiviral for Poultry: Aerosolized Ammunition against Avian Influenza Outbreaks."

The intent of this program is to stimulate dialogue and discussion, foster collaborations and concerted approaches in developing innovative programs aimed at converting the challenges we are facing in infectious disease programs today into opportunities that advance and protect public health interests.

For more information on this event and to see the full agenda, please visit: http://idrtalks.colostate.edu/agenda/

Colorado Bioscience Association Venture Showcase

The Colorado Life Science Innovation Forum is committed to improving the state of the life science industry by providing a venue for business leaders to discuss the most pressing issues shaping the life science industry. 

​

SiVEC Biotechnologies has been selected as one of three emerging Colorado that will have the opportunity to present to a panel of investors for a $7,500 award. 

​

More information about this event can be found on the CBSA website.

Capital Championship

SiVEC Biotechnologies has been selected as an Online Round Finalist for the​ Capital Championship​ and will advance to the Capital Championship​s​ ​held June 8-10, 2016 in Los Angeles, California.​ SiVEC joins​ 9  other finalists​​ ​for the chance to ​pitch and win ​$250,000 cash!​ ​The Capital Championship is a national​ ​entrepreneurial tournament taking place June 8-10, 2016​.

​

For more information on this event, please visit https://capitalchampionship.com/